Construction of a Novel Reactive Oxygen Species-responsive Cationic Copolymer and Its Performance in Gene Delivery

被引:2
|
作者
Han, Xu [1 ]
Zhang, Liuwei [1 ]
Zhang, Qiang [1 ]
Sui, Xihang [1 ]
Qian, Ming [1 ]
Chen, Qixian [1 ]
Wang, Jingyun [1 ]
机构
[1] Dalian Univ Technol, Sch Bioengn, Dalian 116024, Peoples R China
基金
中国国家自然科学基金;
关键词
polycation; charge reversal; gene delivery; ROS-responsive; ascorbic acid; VECTORS; THERAPY; PH;
D O I
10.6023/A21030090
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The development of rapid and active gene release function is the key to improve the efficiency of non-viral gene delivery system. Herein, a novel reactive oxygen-responsive cationic block copolymer non-viral gene delivery vector (termed as pM-pBD) consisting of biocompatible poly(2-methacryloyloxyethyl phosphorylcholine) (pMPC) segment and charge reversible poly[(2-acryloyl)-ethyl-(boronic acid benzyl)-diethylammonium bromide] segment (pBD) was synthesized via reversible addition-fragmentation chain transfer polymerization (RAFT). Dynamic light scattering (DLS) assay and zeta potential measurements, transmission electron microscope (TEM) and gel electrophoresis were performed to characterize pM-pBD/(plasmid DNA, pDNA) complexes. Gel electrophoresis retardation assay displayed that pM-pBD can firmly bind pDNA through electrostatic interaction even in the presence of high concentration of heparin, but capable of releasing pDNA in response to reactive oxygen (such as H2O2). The pM-pBD/pDNA complexes show low cytotoxicity against HeLa cells, even at high weight ratio of pM-pBD and pDNA (N/P) (up to 16) demonstrated by MTT (methylthiazolyldiphenyl-tetrazolium bromide) assay. The pM-pBD/pDNA complexes demonstrated appreciable colloidal stability in the presence of 10% fetal bovine serum. The pM-pBD/pDNA complexes at N/P ratio of 3 displayed spherical morphologies with average diameter of approximate 99.1 nm and zeta potential of approximate +13.8 mV. However, once upon incubation in presence of 1 mmol/L H2O2, the diameter of pM-pBD/pDNA complexes at N/P ratio of 3 was enlarged to 330 nm and zeta potential was reversed to -3.91 mV due to charge reversal of BD responsive to reactive oxygen. Flow cytometry revealed uptake efficiency (88.9%) and the highest transfection efficiency (31.2%) for pM-pBD at N/P ratio of 3 and 16, respectively. The transfection efficiency of pM-pBD/pDNA against HeLa cells was observed to be significantly augmented (1.5-fold) after the addition of ascorbic acid, which could stimulate the production of hydrogen peroxide. Therefore, pM-pBD represented intriguing utilities in fabrication of non-viral gene delivery systems, which enable spatiotemporal control of gene release and thereby facilitated the subsequent transcription machinery.
引用
收藏
页码:794 / 802
页数:9
相关论文
共 24 条
  • [1] Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
    Chen, Qi
    Espey, Michael Graham
    Sun, Andrew Y.
    Pooput, Chaya
    Kirk, Kenneth L.
    Krishna, Murali C.
    Khosh, Deena Senecla
    Drisko, Jeanne
    Levine, Mark
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (32) : 11105 - 11109
  • [2] Gene Therapy in Head and Neck Cancer
    Farmer, Zachary L.
    Kim, Edward S.
    Carrizosa, Daniel R.
    [J]. ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2019, 31 (01) : 117 - +
  • [3] Cationic lipid vectors for plasmid DNA delivery
    Hirko, A
    Tang, FX
    Hughes, JA
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (14) : 1185 - 1193
  • [4] Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy
    Li, Junjie
    Ke, Wendong
    Wang, Lei
    Huang, Mingming
    Yin, Wei
    Zhang, Ping
    Chen, Qixian
    Ge, Zhishen
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 225 : 64 - 74
  • [5] Li S. D., 2007, CONTROL RELEASE, V123, P3
  • [6] Non-viral gene therapy using multifunctional nanoparticles: Status, challenges, and opportunities
    Lin, Guimiao
    Li, Li
    Panwar, Nishtha
    Wang, Jie
    Tjin, Swee Chuan
    Wang, Xiaomei
    Yong, Ken-Tye
    [J]. COORDINATION CHEMISTRY REVIEWS, 2018, 374 : 133 - 152
  • [7] Current Status of Nonviral Vectors for Gene Therapy in China
    Liu, Li
    Yang, Jingyun
    Men, Ke
    He, Zhiyao
    Luo, Min
    Qian, Zhiyong
    Wei, Xiawei
    Wei, Yuquan
    [J]. HUMAN GENE THERAPY, 2018, 29 (02) : 110 - 120
  • [8] Lohr M. Z., 2006, GASTROENTEROL, V44, P4
  • [9] Synthetic DNA delivery systems
    Luo, D
    Saltzman, WM
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (01) : 33 - 37
  • [10] A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
    Nemunaitis, John
    Tong, Alex W.
    Nemunaitis, Michael
    Senzer, Neil
    Phadke, Anagha P.
    Bedell, Cynthia
    Adams, Ned
    Zhang, Yu-An
    Maples, Phillip B.
    Chen, Salina
    Pappen, Beena
    Burke, James
    Ichimaru, Daiju
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    [J]. MOLECULAR THERAPY, 2010, 18 (02) : 429 - 434